GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: Free Trading Tips

TOP CORPORATE NEWS- 22 APR 2019

DHFL declines 10% after Crisil revises credit rating Shares of Dewan Housing Finance Corporation (DHFL) plunged 10% on Monday after rating agency CRISIL downgraded credit rating of the company’s commercial paper and continued on watch negative.Crisil downgraded commercial papers worth Rs850cr from to , with a rating watch of negative implications. The rating agency cited

TOP CORPORATE NEWS- 10 APR 2019

Tata Motors Group global wholesales down 5% in March 2019 Tata Motors Group global wholesales in March 2019, including Jaguar Land Rover, were at 1.45 lakh units, lower by 5%, as compared to March 2018, the company said in the regulatory filing. Global wholesales of all Tata Motors’ commercial vehicles and Tata Daewoo range in

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 29 MAR 2019

Market Live: Nifty likely to open flat. The Nifty50 is likely to open flat-to-lower on Friday tracking mixed trend seen in other Asian markets. The index closed 124 points higher at 11,570 on Thursday. Trends on SGX Nifty indicate a negative opening for the broader index in India, a fall of 29 points or 0.25

TOP CORPORATE NEWS- 28 MAR 2019

Piramal clarifies on reports of acquiring majority stake in DHFL. Piramal Enterprises in its filing to the exchanges on Thursday clarified on a media report that stated Piramal, Baring PE in talks to acquire the majority stake in DHFL.The company said that no such proposal as referred to in the captioned news article has been

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 27 MAR 2019

Closing Bell: Nifty ends below 11,450, Sensex falls 100 points; bank stocks outperform. It is weak closing for the benchmark indices on Wednesday after market erased all its morning gains in the later part of the day. The Sensex was down 100.53 points at 38,132.88, while Nifty was down 38.30 points at 11,445. About 1189

TOP CORPORATE NEWS- 26 MAR 2019

Lupin and YL Biologics get approval for Etanercept biosimilar in Japan Pharma major Lupin announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA) and Yoshindo Inc. in Japan, and Lupin (through its Japanese subsidiary, Kyowa Pharmaceutical Industry Co. Ltd) have received an approval to manufacture and sell

CapitalStars FORUM